Skip to main content
. 2019 Aug 16;60(9):816–823. doi: 10.3349/ymj.2019.60.9.816

Table 2. Left Ventricle Characteristics according to the Presence of Specific Cardiomyopathy.

No CM (n=1119) DCM (n=10) HCM (n=17) LVNC (n=40) p value
LVEDD (mm) 53.5±9.1 68.7±10.3* 50.7±9.9 59.0±10.2*†‡ <0.001
LVESD (mm) 36.3±8.7 59.2±9.8* 31.9±8.1*† 41.9±9.5*†‡ <0.001
IVS thickness (mm) 10.7±2.2 10.1±2.6 14.7±4.2*† 10.7±2.3 <0.001
PW thickness (mm) 10.5±2.0 10.3±2.2 12.2±2.3*† 10.7±2.0 0.005
LV ejection fraction (%) 63±12 29±11* 70±8*† 58±12*†‡ <0.001
LA volume index (mL/m2) 32.0±16.4 46.9±21.4* 36.0±14.4 37.7±16.4* 0.004
e′ velocity (cm/s) 6.1±2.5 3.5±1.4* 4.1±1.6* 6.7±3.0†‡ <0.001
E/e′ 13.0±5.9 20.0±6.6* 17.5±7.3* 12.8±5.4†‡ <0.001
RVSP (mm Hg) 29±11 33±12 25±5 29±10 0.526

CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; IVS, interventricular septum; PW, posterior wall; LV, left ventricle; LA, left atrium; e', early diastolic mitral annular tissue; E/e', ratio of early diastolic mitral inflow velocity to early diastolic mitral annular tissue velocity; RVSP, right ventricular systolic pressure.

Values are presented as mean±standard deviation unless otherwise indicated.

*p<0.05 compared to the group with no CM; p<0.05 compared to the DCM group; p<0.05 compared to the HCM group.